Technicals are strengthening

Posted Tuesday, August 18, 2015 @ 6:57 am by Dr. WishTechnicals are strengtheningGMI4/6GMI-27/8What is the GMI?WORDEN T210841%GMI back to 4 (of 6) and T2108 is at 41% and is at highest reading since July 17. T2108 measures the percentage of NYSE stocks that are above their 40 day simple moving average and shows that large cap industrial stocks may have […]

The Historical Correlation Between Biotech Stocks And … – Benzinga

Related AMGNSocial Media Beat: What The Crowd & Experts Think Of Oil, Biotech & LinkedInStocks Hitting 52-Week HighsAre You Ready For A Pullback BIIB AMGN GILD CELG UTHR JAZZ GOOG FB NFLX APA APC EOG PANW DO RIG(Marketfy Insights)Related CELG5 Biotechs With Catalysts Coming This WeekIs More M&A On The Way For Large-Cap Biotechs?Are You Ready For A Pullback BIIB […]

Biotech Stocks: Safe vs Sexy

By Johanna BennettDo you want safe, or sexy?That’s the question facing biotechnology investors, according to a recent research note from Cowen analysts that previews the sector’s second-quarter financial results.“In heady times, large cap provides a safe haven, smid caps the sex appeal,” reads the note.After shrugging off a selloff in late June, the Nasdaq Biotechnology index has gained 30% since […]

What to Buy in Biotech

By Ben LevisohnUBS analyst Mathhew Roden and team still like biotech stocks, but think it’s time to get more selective, recommending “high quality risk reward names” like Gilead Sciences (GILD) and Vertex Pharmaceuticals (VRTX), while downgrading Amgen (AMGN) and Regeneron Pharmaceuticals (REGN). They explain why:
Freya Ingrid Morales/Bloomberg News

Although we still think that biotech will continue to outperform the broader markets […]

Biotech Stock News (AAVL) (AERI) (AGN) (KYTH) (RHHBY) (REGN …

Avalanche Biotech (NASDAQ:AAVL)Shares of Avalanche Biotech fell as much as 40% in after-hours trading on June 15, 2015 after the company announced results from its phase 2 wet-age related macular degeneration — wet-AMD — trial. The drop is huge but many investors should be assured that the drop was justified because the results were mediocre at best. In addition if […]

Biotech Stocks to Watch in May 2015

Biotech Stocks to Watch in May 2015

Biotech Stocks to Watch in May 2015
By profitconfidentialMay 5, 2015 6:53:59 AM PDT| 19 View(s) | Rating PrintEmailThe best biotech stocks to watch for in May 2015 are businesses that dominate their respective market, command a diverse drug pipeline, and have lots of profits to show for it.Profitability is crucial given that the NASDAQ […]

NDX Leads on Biotech Activity…DJIA Lags on TRV, DD, IBM Earnings…ATI, LRCX Gap Higher…Semis Gain

Three of nine sectors moved higher on Tuesday…XLV, XLP and XLY were the strongest sectors and XLE was the weakest.Breadth weakenedas advancers led decliners 1.001 to 1 on the NYSE and decliners led advancers 1.02 to 1 on the NASDAQ.Tuesday – weakened, mixedMonday – strengthened, advancers ledFriday – weakened, decliners ledThursday – weakened, decliners ledWednesday – strengthened, advancers ledSPY down […]

Biotech Stock Roundup: Favorable Briefing Documents for MDCO…

The Medicines Co. (MDCO – Analyst Report) was in the news for different reasons last week – while the company reported disappointing preliminary top-line results for the first quarter, later on the company received some good news with the FDA issuing positive briefing documents for Kengreal ahead of an advisory panel meeting. Other companies making it to the headlines over […]

Is The Biotech Stock Correction A Buying Opportunity Or A Wake Up Call?

Disclosure: I own shares of AMGN and GILDBiotechnology stocks have been in a sharp correction this week. The iShares Nasdaq Biotechnology ETF dropped close to one-percent in early Thursday trade, following a 1.89% decline on Wednesday; and the SPDR S&P biotech ETF registered similar losses.Is the correction a buying opportunity or a wake up call?Both.On the one side, the correction […]

Rayno Life Science Portfolios: AMGN,CLVS,ILMN,RGEN,TMO

Biotech and Healthcare Stocks Hit New Highs
The market roared back today with healthcare and biotech the strongest sectors.The Healthcare Select SPDR ETF (XLV) was up  2.21% to $73.40. This is a 52 week high. The Euro rallied 1% to 1.057 and that helped large cap companies with revenues outside the US. The XBI SPDR Biotech ETF (XBI) also hit a […]